Clinical Trials Directory

Trials / Completed

CompletedNCT07510217

ERAS Approach for Post-Craniotomy Headache and Psychological Recovery

Enhanced Recovery After Surgery Approach May Mitigate Post-craniotomy Headache and Psychological Derangement

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
139 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This randomized multicenter study involves patients undergoing intracranial surgeries (Population) to evaluate whether a perioperative analgesia protocol including scalp block (SB) with dexmedetomidine (DEX) infusion (Intervention) reduces the incidence and severity of post-craniotomy headache (PCH) compared to standard opioid-based perioperative analgesia (Comparison). The study aims to determine if this Enhanced Recovery After Surgery (ERAS) approach mitigates postoperative pain, reduces opioid consumption, and improves psychological outcomes, including anxiety, depression, and sleep quality.

Conditions

Interventions

TypeNameDescription
DRUGScalp block with 0.5% plain MarcaineA regional anesthetic block targeting the major sensory nerves of the scalp (supraorbital, supratrochlear, zygomaticotemporal, auriculotemporal, greater occipital, and lesser occipital nerves). To provide dense, long-acting local analgesia to the surgical site, preventing the transmission of pain signals during the craniotomy.
DRUGdexmedetomidineStarted intraoperatively and maintained as a continuous infusion until the end of the first postoperative day. To provide systemic analgesia, hemodynamic stability, and anxiolytic (anti-anxiety) effects to mitigate psychological distress and improve sleep quality post-surgery.
DRUGIntraoperative AnalgesiaConventional opioid-based anesthesia. This typically involves the intravenous (IV) administration of strong opioids such as Fentanyl or Sufentanil to manage the intense pain during the craniotomy (bone flap removal) and dural opening. Intermittent boluses or continuous infusion of opioids as determined by the anesthesiologist based on the patient's hemodynamic response (heart rate and blood pressure).

Timeline

Start date
2024-08-10
Primary completion
2025-12-25
Completion
2026-02-20
First posted
2026-04-03
Last updated
2026-04-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07510217. Inclusion in this directory is not an endorsement.